Company / Current Assets per Share
Crinetics Pharmaceuticals, Inc. Current Assets per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$10.97
FY2025
5-year range
$6.41 / $14.80
FY2021-FY2025
Trend
-25.9%
vs FY2024
Sector context
#69 of 210
Health Care
What the data says
At $10.97, Crinetics Pharmaceuticals, Inc.'s current assets per share ranks #69 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 9 years, ranging from $6.41 in FY2022 to $5126.10 in FY2019.
Based on SEC 10-K filings.
10.97 in FY2025 with a 5-year CAGR of +8.4%.
Improved from $9.89 to $10.97 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +19.6%
- 5-Year CAGR
- +8.4%
- 10-Year CAGR
- -
Sector benchmark
#69 of 210 in Health CareTop 33% of 210This company $10.97 Sector average $170.65
▼
-93.6% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 25.9% year-over-year.
- Ranks #69 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2019.
- Lowest current assets per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $10.97 | -25.9% |
| FY2024 | $14.80 | +49.7% |
| FY2023 | $9.89 | +54.3% |
| FY2022 | $6.41 | -11.5% |
| FY2021 | $7.24 | -1.0% |
| FY2020 | $7.32 | -99.9% |
| FY2019 | $5126.10 | +4665.5% |
| FY2018 | $107.57 | +872.5% |
| FY2017 | $11.06 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026